Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Antihistamines Serotonin Agonists Histamine Antagonists • H 1 receptors • inhibit smooth muscle contraction • decrease wheal, flare,and itch • decrease secretions: salivary and lachrymal • CNS: sedation • H 2 receptors • inhibit gastric acid secretion • decrease content and volume of gastric juice • fasting, food stimulated and nocturnal H 1 antagonists • Relief of manifestations of immediate-type hypersensitivity reactions – allergic rhinitis – cold remedies • newer agents “selective” for peripheral H 1 receptors – less sedation (dose dependant) Antihistamine Products • sedating – diphenhydramine (Benadryl) – chlorpheniramine (Chlor-Trimeton) • non-sedating – fexofenadine (Allegra) – loratadine (Claritin) – cetirizine (Zyrtec)* • * metabolite sedating Sedation • dose related even for newer agents • most common ingredient in OTC sleep aids Children’s Formulations • Most available as syrups • Allegra – 30 mg tab • Claritin – 10 mg Redi-tab (fast dissolve) Role of Antihistamines in the Treatment of Allergic Rhinitis Nasal Steroids vs. Antihistamines January 2001 UCDHS Adult Allergic Rhinoconjunctivitis Guidelines Rhinitis Definition Nasal Discharge Blockage Sneeze/Itch Moderate Seasonal or Moderate Perennial Allergen Avoidance Rhinocort , or Nasonex: Nasal Inhalation non-sedating antihistamine, ocular medication "as needed" Severe Long Seasonal or Severe Perennial Allergen Avoidance and Nasal Steroids with Daily non-sedating antihistamine topical antihistamine for conjunctivitis if needed 2 sprays each nostril bid (Rhinocort), qd (Nasonex) Allegra 60 mg bid for two weeks then "as needed" naphazoline opthalmic "as needed" Rhinocort 2-4 sprays each nostril twice a day, Nasonex 2 sprays each nostril daily with Allegra 60 mg twice a day and if needed lodoxamide (Alomide)1-2 drops affected eye(s) 4x day Treatment Failures Evaluate patient compliance and inhaler technique Consider alternative nasal steroid continue Allegra "as needed" For Treament Failures Evaluate patient compliance and inhaler technique Use alternative nasal steroid severe rhinorrhea: Atrovent Nasal 2 sprays each nostil 3-4x day HealthNet: Nasonex, Nasacort Pacificare: Rhinocort, Nasonex, Nasarel REFER TO ALLERGIST IMMUNOTHERAPY WHA: Rhinocort, Nasonex, Nasacort AQ Approved UCDMG P&T Committee January 2001 Reviewed by: T. Albertson S. Teuber, M. E. Gershwin, R. Mowers, J. Fischer HealthNet Jan-Jun 2002 Label_name ALLEGRA ALLEGRA-D CLARINEX CLARINEX TAB 5MG CLARITIN CLARITIN-D 12 HOUR CLARITIN-D 24 HOUR FLONASE NASACORT NASACORT AQ NASALIDE NASAREL RHINOCORT RHINOCORT AQUA ZYRTEC ZYRTEC-D Total Average of Ing_cost Total Sum of Ing_cost Total Number of Rx Data Total Average of Ing_cost 63.59 Sum of Ing_cost 246,090.63 Number of Rx 3,870 Average of Ing_cost 55.34 Sum of Ing_cost 3,209.82 Number of Rx 58 Average of Ing_cost 54.37 Sum of Ing_cost 69,318.89 Number of Rx 1,275 Average of Ing_cost 55.63 Sum of Ing_cost 278.13 Number of Rx 5 Average of Ing_cost 76.42 Sum of Ing_cost 267,921.14 Number of Rx 3,506 Average of Ing_cost 78.77 Sum of Ing_cost 12,131.11 Number of Rx 154 Average of Ing_cost 80.74 Sum of Ing_cost 19,862.94 Number of Rx 246 Average of Ing_cost 53.52 Sum of Ing_cost 73,590.60 Number of Rx 1,375 Average of Ing_cost 51.04 Sum of Ing_cost 9,237.88 Number of Rx 181 Average of Ing_cost 47.78 Sum of Ing_cost 44,821.44 Number of Rx 938 Average of Ing_cost 42.63 Sum of Ing_cost 255.77 Number of Rx 6 Average of Ing_cost 24.26 Sum of Ing_cost 121.30 Number of Rx 5 Average of Ing_cost 37.46 Sum of Ing_cost 13,074.74 Number of Rx 349 Average of Ing_cost 55.24 Sum of Ing_cost 5,192.84 Number of Rx 94 Average of Ing_cost 50.21 Sum of Ing_cost 41,826.46 Number of Rx 833 Average of Ing_cost 49.40 Sum of Ing_cost 493.99 Number of Rx 10 62.57 807,427.68 12,905 other routes of administration • azelastine (Astelin) – nasal spray – allergic rhinitis – decrease side effect profile • Bitter amine taste • sedation (systemic absorption) • olopatadine (Patanol) • emedastine (Emadine) • ophthalmic antihistamine H1 • allergic conjuctivitis and itching • headache, taste perversion, abnormal dreams H 2 Antagonists • Therapeutic Indications – – – – – – duodenal and gastric ulcer gastroesophageal reflux disease (GERD) erosive esophagitis hypersecratory conditions heart burn, indigestion, sour stomach multidrug regimen for the eradication of H.Pylori in peptic ulcer disease UC Davis Primary Care Adult Tx: GERD Diagnosis Gastroesophogeal Reflux Disease Severe GERD (Erosive esophagitis Barrett's esopagus, esophageal stricture) Approve for long term maintance therapy PPI Mild to Moderate GERD (Reflux esophagitis) Surgery Drug Protonix® 40 mg Aciphex® 20 mg Prevacid® 30 mg Nexium® 20 mg Prilosec® 20 mg 8 weeks therapy "Step Up" Start with High Dose H2 cimetidine 800 mg bid ranitidine 150 mg bid Beck IT et al. The Second Canadian Consensus Conf. on Management of Patients with GERD. Can J Gastroenterol 1997;11 suppl B 7-20. Katz PO. Treatment of GERD: Use of Algorithms. Am J Gastroenterol 1999;94(11)suppl:3-10. Improvment No Improvment Reduce to maintance dose cimetidine 400 mg hs ranitidine 150 mg hs Protonix 40 mg daily Aciphex 20 mg daily Prevacid 30 mg daily Prilosec/Nexium 20 mg daily Re-evaluate patient symptoms at 16 weeks total therapy Re-evaluate patient symptoms at 16 weeks total therapy Reviewed by; T. Albertson, J. Lee, J. Fischer, R. Mowers discontinue drug continue H2 maintance Improvement No Improvement discontinue drug therapy change to H2 maintance therapy Refer to GI Specialist UCDMC P&T Committee January 2002 June 2001 AWP/ea 3.00 3.70 3.88 3.99 4.15 HealthNet Jan-Jun 2002 Label_name ACIPHEX Data Total Average of Ing_cost 119.73 Sum of Ing_cost 275,734.11 Count of Pt_first_name 2303 CIMETIDINE Average of Ing_cost 8.96 Sum of Ing_cost 7,179.47 Count of Pt_first_name 801 CIMETIDINE HCL Average of Ing_cost 38.36 Sum of Ing_cost 191.82 Count of Pt_first_name 5 FAMOTIDINE Average of Ing_cost 27.44 Sum of Ing_cost 2,908.76 Count of Pt_first_name 106 NEXIUM Average of Ing_cost 115.34 Sum of Ing_cost 7,843.10 Count of Pt_first_name 68 PREVACID Average of Ing_cost 119.92 Sum of Ing_cost 17,627.56 Count of Pt_first_name 147 PRILOSEC Average of Ing_cost 139.62 Sum of Ing_cost 73,021.10 Count of Pt_first_name 523 PROTONIX Average of Ing_cost 88.35 Sum of Ing_cost 172,897.16 Count of Pt_first_name 1957 RANITIDINE TAB 150MG Average of Ing_cost 6.69 Sum of Ing_cost 100.31 Count of Pt_first_name 15 RANITIDINE TAB 300MG Average of Ing_cost 7.57 Sum of Ing_cost 30.29 Count of Pt_first_name 4 RANITIDINE HCL Average of Ing_cost 10.26 Sum of Ing_cost 21,961.43 Count of Pt_first_name 2140 Total Average of Ing_cost 71.82 Total Sum of Ing_cost 579,495.11 Total Count of Pt_first_name 8069 Adverse Reactions • low incidence of side effects • headache and fatigue - 1% • cimetidine – highest incidence of gynecomastia (1- 4%) – P450 drug interactions • decrease digoxin levels • increase flecainide activity Serotonin 5-HT1 agonists • Treatment of Migraine with or without aura. • Acute treatment of Cluster headaches. • Drugs are combination of 5-HT (1A, 1B, 1D, 1E, 1F, 7) • No activity at 5HT 2-4 receptors, adrenergic, muscarinic, dopaminergic Mechanism of Action • Stimulation 5HT-1 receptors in extracerebral and intracranial blood vessels results in vasoconstriction. Also seen is an inhibition of neuropeptide release and decreased transmission in trigeminal pain pathways. • It is thought cranial vessel dilation induced by release of vasoactive peptides from sensory nerve endings in an active trigeminal system my be a root cause of Migraine. Prototype agents • sumatriptan (Imitrex) – Tablets, nasal spray, injection • rizatriptan (Maxalt) • Several others Common adverse events • Generally well tolerated • Events with 5% rate: paresthesia, nausea, dizzsiness, fatigue, dry mouth, headache, flushing • Rare but serious events: cardiac events with fatalities, cerebrovascular events with fatalities (hemorrhage, stroke, others) Rebound headache • The risk of rebound headaches increases with the number of doses taken. • Patient information: – Take as soon as possible – Second dose may be taken if no response in 2 hours – Limit injections to 2 per 24 hours – Contact MD before taking additional doses if no response • Other drugs for Migraine Treatment • Ergot alkaloids such as dihydroergotamine (Migranal, DHE 45) • Migraine Prophylaxis – – – – Beta blockers Calcium channel blockers NSAID Valproate